Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0910 ECP Generate EMBARGO 6AM ET THURS
BioCentury & Getty Images

Emerging Company Profile

Generate: applying machine learning to protein design

How Generate Biomedicines is using machine learning to guide therapeutic protein design

Flagship Pioneering’s latest start-up Generate Biomedicines is accelerating therapeutic protein generation with machine learning.

Sep 10, 2020 | 10:03 AM GMT

Generate Biomedicines, the latest company to emerge from Flagship Pioneering, has a machine learning platform for creating new biologic therapies that should sidestep the trial and error process used to

Read the full 797 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE